chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an 8 year old male on 08-JAN-2002 and 16-JUL-2005 was vaccinated with the first and second dose of MMR respectively (route, site and lot number not reported). On 01-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 19-NOV-2009). The patient also experienced parotitis and was afebrile. On 17-NOV-2009, the first blood work was done which revealed serum IgM negative, serum IgG 4.41, and serum amylase 88. On 07-DEC-2009, the second blood work was done which revealed serum IgM <1:10, serum IgG 9.27, and serum amylase 39. The outcome for mumps was not reported. Follow-up information was received which reported that the 8 year old patient (also reported as 5 year old on 06-DEC-2009 (previously reported as on 01-DEC-2009) experienced mumps and orchitis. The patient was diagnosed on 06-DEC-2009. The patient also experienced left jaw swelling and pain. This is one of several reports from the same source. No further information is available.
Soreness in left arm/shoulder/neck areas. States "I can feel the vaccine working it's way through my muscles". States has a "boil" or fluid collection in elbow area. Slight swelling above injection site. Self treated with TENS unit, ibuprofen with some relief.
Pt received imm 10-25-07 Pediarix, HIB, Prevnar. Admitted through the ER on 11-4-07 with abscess to right thigh. Abscess was I & D'd and pt was put on IV abx - D/C on 11-9-07. Red, swollen knot (R) thigh, hard to touch, fever 102.  2/12/2008 MR received for DOS 11/4-9/2007 with D/C DX:  Abscess to R thigh.  Urinary Tract Infection.  Leucopenia. Child presented with abscess to R thigh requiring I&D in the ER.  WBCs noted to be very low. Abscess tx with IV abx. Leucopenia to be followed as outpt  Per 60 day follow up: Pt has scar at site of abcess in thigh-has fatty defect. Underlying congenital leukopenia still present & under evaluation.
Itchiness across body; Itchiness  at injection site; sore swollen throat.; Swollen throat; Spine pain; Back inflammation; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: unknown) via an unspecified route of administration in the arm left on 10Apr2021 at 16:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included seizures (temporal limbic/parietal), tourettism (Tourettes Bipolar), post-traumatic stress disorder (Ptsd Seizures), asperger's disorder, obsessive-compulsive disorder, autism, social anxiety disorder (Social anxiety), panic attacks, claustrophobia (Severe claustrophobia), migraine, psychosis, pre-diabetes (hyperglycemic), prostatitis (Prosttitus), irritable bowel syndrome, neuropathy (Severe neuropathy), syncope vasovagal, fainting, dizzy, fever, lower back extra vertebra fused to L5, issues heart condition, loose joints syndrome (high risk break/sprain disorder i.e. elderly youth syndrome), ulcer (issues with ulcers: spicy, citrus, soda, allergy to garlic flavoured cigs), milk allergy, allergy to plants (citrus, hemp, weed, corn), allergy to nuts (walnuts, almonds, cashews), allergy to meat (beef, pork), allergy to vegetable (onion, garlic, carrots), allergy to animal (elm mold, ragweed dog, cat goose) and allergy to all forms of perfume and cologne most forms of incense vape fluids near-lethal allergy to some forms of flavoured cigarettes (throat seals, blackout, cannot breathe). Concomitant medications included buspirone 5 mg, doxycycline and diclofenac sodium (DYCLO). The patient previously took cyclobenzaprine (seizure hiccups, severe fever), meloxicam (seizures, severe suicidal depression, severe fever), diclofenac (seizures, severe fever), gabapentin /neurontin (seizure spasms and convulsive diarrhea), omeprazole (seizure hiccups, severe constipation, stomach pain) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:15, the patient experienced itchiness across body, itchiness at injection site, sore throat, swollen throat, spine pain and back inflammation. Therapeutic measures were taken as a result of events and included treatment with itch cream, ice packs, pain medication. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events itchiness across body, itchiness at injection site, sore throat, swollen throat, spine pain and back inflammation was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Breakthrough case admission after 2 vaccines MOderna 4/23/21 Lot# 007C;  Moderna 5/21/21 Lot# 035C21A
On 11/6/00, returned to clinic with swelling of right arm and itching around swollen area. Swelling measured 4" X 5" with mild erythema around outer edge of swelling. No problems breathing. Client to take OTC Benadryl 50mg every 6 hours and Tylenol every 4 hours and to put ice compresses to site. On 11/7/00, swelling increased up to 8" X 9". No itching. Swelling extended to shoulder and elbow. Was seen in clinic and told to continue conservative measures and return if it persists. On 11/8/00, client returned with swelling extended to below elbow with erythematous areas at elbow. Enter upper right arm was warm to touch. Temperature was 97.5F. Denies any fever or chills or difficulty breathing. Stated area was itching again particularly around the elbow area. Nurse consulted with doctor. Pt is to continue conservative measures and use topical OTC Cortaid type cream for itching. If fever and/or chills develop to go to ER. On 11/9/00, client returned and swelling and redness was improved. Still swollen at elbow with pinkness noted. Client to continue with current treatment.
This spontaneous report was received from a licensed practical nurse (L.P.N) via a telephone call, concerning a 4 year old female patient. No concurrent conditions or medical history were reported. On 08-MAY-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (Lot # K018142 Expiration date: 10-APR-2016) (dose, frequency and anatomical location of administration were not reported). No concomitant therapies or adverse experiences were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Immediately as needle removed child became pale & started to have shaking & disorientation. Child was asked to lay down after fainting and observed for 30 minutes. Recovered completely.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 22-JUN-2017, the patient was vaccinated with expired dose of VAQTA lot # M031695, expiration date 26-MAY-2017 (dose and route of administration were not reported) for prophylaxis. The nurse stated that a medical assistant administered VAQTA without checking the expiration date. No adverse effects noted and no additional information given. Additional information has been requested.
heart issues/a fluttering heart; palpitations; heart skipping a beat; This spontaneous case was reported by a non-health professional and describes the occurrence of CARDIAC DISORDER (heart issues/a fluttering heart), PALPITATIONS (palpitations) and EXTRASYSTOLES (heart skipping a beat) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (heart issues/a fluttering heart), PALPITATIONS (palpitations) and EXTRASYSTOLES (heart skipping a beat). At the time of the report, CARDIAC DISORDER (heart issues/a fluttering heart), PALPITATIONS (palpitations) and EXTRASYSTOLES (heart skipping a beat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication information was given. Patient did not see a doctor about his symptoms.   This case was linked to MOD-2021-404352 (Patient Link).
Grand Mal seizures that started on Nov 22. Second seizure was Dec 8 and third Dec 12.
Inj of KINRIX given left thigh -> positive local edema, negative erythema, negative urticaria, positive warmth.
Patient developed a local area of redness and swelling, warm to the touch surrounding the Zostavax injection site on the posterior of her left arm about 2-3 inches in diameter.
Extremely muscle fatigue, low grade fever, nausea, shaking, headache, stomach discomfort.
His grandma got one and two weeks later had the onset of dementia.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEMENTIA (medically significant), outcome "unknown", described as "His grandma got one and two weeks later had the onset of dementia".  Clinical course: The PRIVATE owns Moderna. His grandparents know they messed up in getting the vaccines. They know they messed up. His grandma got one and two weeks later had the onset of dementia. It doesn't matter to file an adverse event report. His grandfather had one on VAERS, vetted and called the (hospital name withheld) and (hospital name withheld) doctor and not attributed to the (hospital name withheld), so it was reviewed and deemed not attributed to the vaccine so it was removed. He has the screen shots of the before and after. He knows others who have had their VAERS reports deleted.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
received first dose of Astra Zeneca covid-19 vaccine and second dose of Moderna Covid-19; first dose of astra zeneca covid 19 vaccine in 03April2021,The patient received second dose of Moderna Covid-19 vaccine today, 08June2021; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received first dose of Astra Zeneca covid-19 vaccine and second dose of Moderna Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of astra zeneca covid 19 vaccine in 03April2021,The patient received second dose of Moderna Covid-19 vaccine today, 08June2021) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received first dose of Astra Zeneca covid-19 vaccine and second dose of Moderna Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of astra zeneca covid 19 vaccine in 03April2021,The patient received second dose of Moderna Covid-19 vaccine today, 08June2021). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (received first dose of Astra Zeneca covid-19 vaccine and second dose of Moderna Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of astra zeneca covid 19 vaccine in 03April2021,The patient received second dose of Moderna Covid-19 vaccine today, 08June2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information provided.
No adverse effects; On 29-NOV-2013 at age 20 years, patient received the first dose of the HPV vaccination series, GARDASIL Quadrivalent/ the patient received the second dose in the HPV vaccination series on 23-MAY-2019 and it was GARDASIL 9.; On 29-NOV-2013 at age 20 years, patient received the first dose of the HPV vaccination series, GARDASIL Quadrivalent/ the patient received the second dose in the HPV vaccination series on 23-MAY-2019 and it was GARDASIL 9.; This spontaneous report was received from a pharmacist and refers to an adult patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.   On 29-NOV-2013, at age of 20 years, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (the first dose of the human papillomavirus (HPV) vaccination series) (dose, site and route of administration, lot # and expiration date were not reported) for prophylaxis. On 23-MAY-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (the second dose of the HPV vaccination series) (dose, site and route of administration, lot # and expiration date were not reported) for prophylaxis. No adverse effects were reported.
Full body rash on April 11. Started with ears, face and went down entire body to my toes.  (Did not have rash on my stomach, butt or breasts. Used Benadryl and tylenol and it went away. Felt like my body was on fire and very hot to the touch, but no fever. Full body rash again on April 19.  Started with ears, face again.  Immediately took Benadryl and tylenol.  This time we could watch the rash spread throughout my body.  This time included stomach, not breast or butt.  Once again very hot to the touch, put ice packs on my chest and arms and legs.  8 hours later it was gone.  Very sensitive skin to the touch could not put on any clothing at all.
The patient developed progressive sensory deficits on face, arms, hand, and body over a period of 3 days.  She was diagnosed with pure sensory Guillain-Barre syndrome by the pediatric neurologist at Medical Center.  Her symptoms began resolving by day of illness 6, and she was not treated with IVIG.
felt weak; shaky; felt extremely tired, worn out, exhausted and fatigued; breathing might be a little bit worse but not much; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Apr2021 13:55 (Lot number: ER8737) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Emphysema" (unspecified if ongoing); "Depression" (unspecified if ongoing); "neuropathy of the feet" (unspecified if ongoing); "two hernias" (unspecified if ongoing); "brain damage" (unspecified if ongoing), notes: The patient reported that he's got brain damage, he's old and senile, crazy.; "too many concussions" (unspecified if ongoing); "memory department is messed up" (unspecified if ongoing), notes: memory department is messed up from too many concussions. Concomitant medication(s) included: ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE; SPIRIVA RESPIMAT. The following information was reported: ASTHENIA (non-serious) with onset 09Apr2021, outcome "unknown", described as "felt weak"; TREMOR (non-serious) with onset 09Apr2021, outcome "recovered" (09Apr2021), described as "shaky"; FATIGUE (non-serious) with onset 09Apr2021, outcome "not recovered", described as "felt extremely tired, worn out, exhausted and fatigued"; DYSPNOEA (non-serious) with onset Apr2021, outcome "not recovered", described as "breathing might be a little bit worse but not much".  No follow-up attempts are possible. No further information is expected.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter. No treatment medications were provided by reporter.
1/27/22 pt comes from ED; admitted to Medical Center with c/o feeling ill on 1/26/22 - fatigue, cough, congestion, SOB, dyspnea with exertion; O2 saturation 80% on RA; O2 supplementation; positive COVID test; BiPAP; given Decadron, ABX; transferred to ICU; DNR; status changed to DNR comfort care only; pt expired in the hospital
Ten days after administration of DTaP, Hib, MMR and Prevnar on 05/24/2005 treated at ER for febrile seizure and bilateral otitis media.
States he was hospitalized for a neurological disorder d/t toxification ingested on a paint job he was performing.  Upon his discharge the nurse offered the vaccination.  States he got the vaccination and was discharged.  The next morning he woke up feeling like he was having a stroke in his stomach.  Its a super weird mesh raised feeling in his stomach which feels like cat hairs are raised up in his stomach.  States this scared him so bad causing him to go to the ER and a MRI and x-ray with contrast was performed but this was for the neurological disorder he was admitted to hospital for but nothing has been done about his stomach and the issues are still an issue still over 2 months later.  States both arms are super cold and it feels like the needles are still in his arm.  States this didn't begin until after he got the vaccination and has still been an issue to date since the vaccination.  States his doctor sent him to have a sonogram on his arm where the needles were inserted but they still hadn't got the results back yet.
Pt had a bruise and "hard lump" to injection site on RIGHT ARM (Pneumovax side). I assessed in clinic when she mentioned it to me on 2/1/16. On that day (13 days later) had 2cm indurated area with healing bruise of same size.
1/20/22 pt presents to ED with c/o SOB worsening over past 2 wks; on 3 LNC O2 at home, but has needed more lately; found to be positive for COVID; admitted; chest CTA suggests neoplastic process in lung; EKG shows sinus tachycardia; pt given ABX, dexamethasone; pt doesn't want treatment for lung mass; requests hospice and to be sent home; pt dc'd to home with Hospice on 1/24/22; pt died at home
I got my first vaccine the morning of April 11th at 11am.  I felt fine all day and woke up that morning around 4am with body aches and sweats.  When I got out of bed I felt very dizzy and disoriented.  It has been 9 days and I still have chronic dizziness and am unable to drive.  My sense of balance and vision is distorted and I am also having mild headaches.  I am scared that this will never go away and that I will be disabled.
PT. CALLED ON 10/14/23 STATING THAT AFTER HER COVID VACCINE THAT WAS PLACED ON HER RIGHT DELTOID ON 10/9/23  HER RIGHT ARM BECAME SORE THEN ON 10/10/23 HER SORENESS DEVELOPED INTO A THROBBING PAIN AND ACHY PAIN   THAT LIMITED HER RANGE OF MOTION TO HER RIGHT ARM STATES THAT THE PAIN HAS NOT IMPROVED SINCE 10/10/23  DENIES REDNESS TO INJECTION SITE AND ARM SWELLING STATES PAIN IS NOT AT INJECTION SITE BUT BELOW INJECTION SITE, AROUND RIGHT SHOULDER JOINT, AND RIGHT UPPER BACK PT. STATES FLU SHOT GIVEN ON LEFT ARM W/O SYMPTOM PT. WAS VERIFIED USING TWO PT. IDENTIFIERS AND ADVISED PT. TO F/U AT URGENT CARE/ER TODAY ON 10/14/23 AND F/U WITH PCP PT. AGREES WITH PLAN OF CARE
Myalgia, Arthralgia, Weakness, Pain/redness/itching/swelling at injection site  Narrative:
Annular redness and swelling of upper arm, 5.5 cm in diameter (increasing in size since 6/1/21), no streaking, positive warmth, no tenderness, slight hardening /induration under skin
At 10 pm the night of injection, severe shaking chills for about 45 min; then feverish/achy feeling the rest of the nigh.  By noon, the next day, feeling fine.
This case was received from a health professional on 17 July 2007.  A 20-year-old male patient with no reported medical history received an intramuscular left deltoid injection of Menactra (lot number U2370AA).  Approximately 12 hours later, he experienced chest pain, headache, malaise, chills, and a fever of 102 degrees Fahrenheit.  He was seen in his physician's office on 17 July 2007, and was treated with Advil.  At the time of the report, the event was resolving.  Follow-up information received on 27 August 2007 from a health care professional.  The patient has medical history of allergy to "PCN" (penicillin) and  Cephalosporins.  He had no illnesses at the time of the Menactra vaccination on 16 July 2007.  The patient had no relevant diagnostic tests or laboratory data performed for the reported events in this case.  It was reported the patient recovered from the events, however a recovery date was not provided.  No further information is expected.